<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00572208</url>
  </required_header>
  <id_info>
    <org_study_id>Gabapentin01</org_study_id>
    <secondary_id>2007-001479-12</secondary_id>
    <nct_id>NCT00572208</nct_id>
  </id_info>
  <brief_title>Gabapentin for Postoperative Pain Management After Cardiac Surgery With Median Sternotomy</brief_title>
  <official_title>Gabapentin for Postoperative Pain Management After Cardiac Surgery With Median Sternotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study we will focus on the postoperative recovery. A successful postoperative
      recovery should bring the patient to at least to the pre-surgical level. This can probably be
      achieved by a multimodal approach where at least postoperative pain and PONV are managed.

      The surgical injury results in immobilisation which again can result in impaired cardiac,
      respiratory and musculoskeletal system. Pain relief is a prerequisite for mobilisation and an
      early return to the pre-surgical level. The preferred drugs for postoperative pain management
      are opioids. Although opioids are known to be an effective analgesia, they have a series of
      side effects: nausea, vomiting, constipation, respiratory deficiency, delirium among others.

      Gabapentin has been tested for post operative pain. Randomized Clinical Trials have reported
      a significant better pain scores with Gabapentin in several studies -most of them restricted
      to the postoperative period in the post-anaesthesia care unit in many different kind of
      surgeries.

      We want to test if Gabapentin can be used instead of opioids for treatment of postoperative
      pain after heart surgery by median sternotomy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">February 2009</completion_date>
  <primary_completion_date type="Anticipated">February 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Morphine consumption</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>PONV</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication side effects</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS score and medication 30 days after the operation</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gabapentin group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin group</intervention_name>
    <description>Gabapentin group:
Preoperative (2 h before surgery): Tablet Gabapentin 1200 mg (blinded)
st Postoperative day: Tablet Gabapentin 300 mg twice a day (blinded)
nd Postoperative day: Tablet Gabapentin 300 mg twice a day (blinded)
rd Postoperative day: Tablet Gabapentin 300 mg twice a day (blinded)
th Postoperative day: Tablet Gabapentin 300 mg twice a day (blinded)
th Postoperative day: Tablet Gabapentin 300 mg twice a day (blinded)</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients scheduled for elective cardiac surgery with median sternotomy at the
             department of cardiac surgery, Aarhus University Hospital, Skejby.

          2. Patients older than 18 years.

        Exclusion Criteria:

          1. Patients unable to cooperate.

          2. Known allergy for Gabapentin or opioids.

          3. Acute pancreatitis

          4. History of gastric or peptic ulcer.

          5. History of alcohol or drug abuse.

          6. Chronic pain or daily intake of analgesics or corticosteroids.

          7. Gastrointestinal obstruction

          8. Impaired liver function.

          9. Impaired kidney function.

         10. Previous operation with median sternotomy

         11. Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vibeke Hjortdal, MD, Dr.sci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiothoracic and Vascular Surgery Department, Aarhus University Hospital, Skejby</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Imran Parvaiz, MD</last_name>
    <phone>+45 40547377</phone>
    <email>imran@dadlnet.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mariann T Jensen, MD</last_name>
    <email>MTZ@sks.aaa.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cardiothoracic and Vascular Surgery Department, Aarhus University Hospital, Skejby</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Imran Parvaiz, MD</last_name>
      <phone>+45 40547377</phone>
      <email>imran@dadlnet.dk</email>
    </contact>
    <contact_backup>
      <last_name>Mariann T Jensen, MD</last_name>
      <email>MTZ@sks.aaa.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Vibeke Hjortdal, MD, Dr.Sci</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Imran Parvaiz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mariann T Jensen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiothoracic and vascular department, Skejby Sygehus</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariann Tang Jensen, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2007</study_first_submitted>
  <study_first_submitted_qc>December 11, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2007</study_first_posted>
  <last_update_submitted>February 12, 2009</last_update_submitted>
  <last_update_submitted_qc>February 12, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 13, 2009</last_update_posted>
  <responsible_party>
    <name_title>Vibeke Hjortdal, Professor, Consultant, Dr. Sci., PhD.</name_title>
    <organization>Cardiothoracic and Vascular Surgery Department, Aarhus University Hospital, Skejby</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>gamma-Aminobutyric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

